pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences is a pharma organization headquartered in Hayward, USA. It trades on NYSE under ticker RCUS. Primary therapeutic focus areas include Advanced Cancer, Non-small Cell Lung Cancer, Metastatic Clear Cell Re
3928 Point Eden Way, Hayward, California 94545, US HQ
2015 Founded
655 Employees
Public company Type
RCUS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
Domvanalimab
Phase 3 · small molecule · Advanced Upper Gastrointestinal Tract Adenocarcinoma
Domvanalimab for Advanced Upper Gastrointestinal Tract Adenocarcinoma is a Phase 3 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Internal code STAR-221
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Arcus Biosciences
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Advanced Upper Gastrointestinal Tract Adenocarcinoma
- Status
- active
- Trials
- 1